N/A
Completed N=330
The Use of a Novel Peer Education Program for Improving PTSD Treatment Engagement Among Veterans
Source: ClinicalTrials.gov NCT03521999 ↗Enrolled (actual)
330
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcomePrimary: PTSD Treatment Engagement (Yes/no) — 137; 132 Participants
Summary
Behavioral health problems among Veterans have raised awareness of the critical need for more reliable, effective, and accessible ways to recognize those in need, direct them to help, and ensure that they receive the best evidence-based care available. AboutFace is a novel peer education program that features the personal stories of Veterans and is designed to improve Veterans' likelihood of engaging in Post Traumatic Stress Disorder (PTSD) specialty care. Using a randomized controlled study design the investigators propose to compare the efficacy of AboutFace relative to standard care for improving treatment engagement and outcomes. Additional data from VA providers will provide valuable information on wide scale implementation and dissemination of AboutFace. If AboutFace increases access of services, data will have broad implications for overcoming barriers to care for Veterans with PTSD and other stigmatized conditions.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PTSD Treatment Engagement (Yes/no) |
137; 132 | — |
| PRIMARY Total Number of PTSD Treatment Sessions |
8.5; 8.5 | — |
| SECONDARY Posttraumatic Stress Disorder Checklist-5 (PCL-5) |
49.9; 46.9 | — |
| SECONDARY Endorsed and Anticipated Stigma Inventory (EASI) |
99.33; 98.76 | — |
| SECONDARY Patient Health Questionnaire (PHQ-8) |
15.3; 14.5 | — |
| SECONDARY Quality of Life Index (QLI) |
15.5; 15.5 | — |
Eligibility Criteria
Inclusion Criteria
- Veterans must be referred for a PTSD evaluation through the Charleston VAMC PTSD Clinic Team (PCT) and Telehealth Programs and recommended for PTSD specialty care through the clinic.
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT03521999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.